Welcome to our dedicated page for SELECTIS HEALTH news (Ticker: $GBCS), a resource for investors and traders seeking the latest updates and insights on SELECTIS HEALTH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SELECTIS HEALTH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SELECTIS HEALTH's position in the market.
Selectis Health, Inc. (OTC: GBCS) has entered into a definitive Purchase and Sale Agreement to sell Archway Transitional Care Center in Georgia for $6.75 million. The transaction is expected to enhance the company's balance sheet and provide flexibility for further initiatives. The sale includes certain real property in Macon, Bibb County, Georgia, with the Purchaser having a 45-day Inspection Period. Upon completion of the sale, Selectis Health will continue to own and operate various healthcare facilities in Georgia and other states.